Curcumin rescues Caenorhabditis elegans from a Burkholderia pseudomallei infection

Frontiers in Microbiology

Volumn 6, Issue APR, 2015, Pages

  Eng, Su Anne ^a   Nathan, Sheila ^a  

^a UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

Author keywords

Antibiotic resistance; Bacterial attenuation; Burkholderia pseudomallei; Caenorhabditis elegans; Curcumin

Indexed keywords

ALPHA HEMOLYSIN; CURCUMIN; DIMETHYL SULFOXIDE; EGTAZIC ACID; HEMOLYSIN; NATURAL PRODUCT; PROTEINASE; SIDEROPHORE; TETRACYCLINE; TRANSCRIPTOME; TRIACYLGLYCEROL LIPASE; VIRULENCE FACTOR;

ADULT; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; BIOFILM; BURKHOLDERIA PSEUDOMALLEI; CAENORHABDITIS ELEGANS; COLONY FORMING UNIT; CONTROLLED STUDY; DISK DIFFUSION; ENTEROCOCCUS FAECALIS; ENZYME ACTIVITY; ESCHERICHIA COLI; GENE EXPRESSION; INHIBITION ZONE; MELIOIDOSIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROPLATE READER; MINIMUM BACTERICIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; NEMATODE; NONHUMAN; PSEUDOMONAS AERUGINOSA; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; SCREENING; SURVIVAL FACTOR;

BACTERIA (MICROORGANISMS); BURKHOLDERIA PSEUDOMALLEI; CAENORHABDITIS ELEGANS;

EID: 84930948732     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2015.00290     Document Type: Article

References (68)

1. Adonizio, A., Leal, S. M. Jr. Ausubel, F. M., and Mathee, K. (2008). Attenuation of Pseudomonas aeruginosa virulence by medicinal plants in a Caenorhabditi elegans model system. J. Med. Microbiol. 57, 809-813. doi: 10.1099/jmm.0.47802-0.
2. Afzal, A., Oriqat, G., Khan, M. A., Jose, J., and Afzal, M. (2013). Chemistry and biochemistry of terpenoids from Curcuma and related species. J. Biol. Active Prod. Nat. 3, 1-55. doi: 10.1080/22311866.2013.782757.
3. Aggarwal, B. B., Sundaram, C., Malani, N., and Ivhikawa, H. (2007). Curcumin: the Indian solid gold. Adv. Exp. Med. Biol. 595, 1-75. doi: 10.1007/978-0-387-46401-5_1.
4. Alice, A. F., Lopez, C. S., Lowe, C. A., Ledesma, M. A., and Crosa, J. H. (2006). Genetic and transcriptional analysis of the siderophore malleobactin biosyntesis and transport genes in the human pathogen Burkholderia pseudomallei. J. Bacteriol. 188, 1551-1556. doi: 10.1128/JB.188.4.1551-1566.2006.
5. Ansel, H. C., Norred, W. P., and Roth, I. L. (1969). Antimicrobial activity od dimethyl sulfoxide against Escherichia coli, Pseudomonas aeruginosa, and Bacillus megaterium. J. Pharm. Sci. 58, 836-839. doi: 10.1002/jps.2600580708.
6. Antunes, L. C., Ferreira, R. B., Buckner, M. M., and Finlay, B. B. (2010). Quorum sensing in bacterial virulence. Microbiology 156, 2271-2282. doi: 10.1099/mic.0.038794-0.
7. Ashdown, L. R., and Koehler, J. M. (1990). Production of hemolysin and other extracellular enzymes by clinical isolates of Pseudomonas pseudomallei. J. Clin. Microbiol. 28, 2331-2334.
8. Baum, L., and Ng, A. (2004). Curcumin interaction with copper and iron suggested one possible mechanism of action in Alzheimer's disease animal models. J. Alzheimers Dis. 6, 367-377.
9. Beanan, M. J., and Strome, S. (1992). Characterization of a germ-line proliferation mutation in C. elegans. Development 116, 755-766.
10. Cegelski, L., Marshall, G. R., Eldridge, G. R., and Hultgren, S. J. (2008). The biology and future prospects of antivirulence therapies. Nat. Rev. Microbiol. 6, 17-27. doi: 10.1038/nrmicro1818.
11. Cheng, A. C., and Currie, B. J. (2005). Melioidosis: epidemiology, pathophysiology, and management. Clin. Microbiol. Rev. 18, 383-416. doi: 10.1128/CMR.18.2.383-416.2005.
12. Chieng, S., Carreto, L., and Nathan, S. (2012). Burkholderia pseudomallei transcriptional adaptation in macrophages. BMC Genomics 13:328. doi: 10.1186/1471-2164-13-328.
13. Choh, L. C., Ong, G. H., Vellasamy, K. M., Kalaiselvam, K., Kang, W. T., Al-Maleki, A. R., et al. (2013). Burkholderia vaccines: are we moving forward? Front. Cell. Infect. Microbiol. 5:5. doi: 10.3389/fcimb.2013.00005.
14. Clatworthy, A. E., Pierson, E., and Hung, D. T. (2007). Targeting virulence: a new paradigm for antimicrobial therapy. Nat. Chem. Biol. 3, 541-548. doi: 10.1038/nchembio.2007.24.
15. Clinical and Laboratory Standards Institute (CLSI). (2006). Performance Standards for Antimicrobial Disk Susceptibility Test: Approved Standard, 9th Edn CLSI Document M2-A9. Wayne, PA: Clinical and Laboratory Standard Institute.
16. Cruz-Migoni, A., Hautberque, G. M., Artymiuk, P. J., Baker, P. J., Bokori-Brown, M., Chang, C. T., et al. (2011). A Burkholderia pseudomallei toxin inhibits helicase activity of translation factor eIF4A. Science 334, 821-824. doi: 10.1126/science.1211915.
17. de la Fuente-Nunez, C., Reffuveille, F., Fernandez, L., and Hancock, R. E. (2013). Bacterial biofilm development as an multicellular adaptation: antibiotic resistance and new therapeutic strategies. Curr. Opin. Microbiol. 16, 580-589. doi: 10.1016/j.mib.2013.06.013.
18. Easton, D. M., Nijnik, A., Mayer, M. L., and Hancock, R. E. (2009). Potential of immunomodulatory host defense peptides as novel anti-infectives. Trends Biotechnol. 27, 582-590. doi: 10.1016/j.tibtech.2009.07.004.
19. Eijkelkamp, B. A., Hassan, K. A., Paulsen, I. T., and Brown, M. H. (2011). Investigation of the human pathogen Acinetobactor baumannii under iron limiting conditions. BMC Genomics 12:126. doi: 10.1186/1471-2164-12-126.
20. Gan, Y. H., Chua, K. L., Chua, H. H., Liu, B., Hii, C. S., Chong, H. L., et al. (2002). Characterization of Burkholderia pseudomallei infection and identification of novel virulence factors using a Caenorhabditis elegans host system. Mol. Microbiol. 44, 1185-1197. doi: 10.1046/j.1365-2958.2002.02957.x.
21. Garsin, D. A., Sifri, C. D., Mylonakis, E., Qin, X., Singh, K. V., Murray, B. E., et al. (2001). A simple model host for identifying Gram-positive virulence factors. Proc. Natl. Acad. Sci. U.S.A. 98, 10892-10897. doi: 10.1073/pnas.191378698.
22. Gunes, H., Gulen, D., Mutlu, R., Gumus, A., Tas, T., and Eren Topkaya, A. (2013). Antibacterial effects of curcumin: an in vitro minimum inhibitory concentration study. Toxicol. Ind. Health. doi: 10.1177/0748233713498458. [Epub ahead of print].
23. Hamill, P., Brown, K., Jensses, H., and Hancock, R. E. (2008). Novel anti-infectives: is host defense the answer? Curr. Opin. Biotechnol. 19, 628-636. doi: 10.1016/j.copbio.2008.10.006.
24. Hara, Y., Mohamed, R., and Nathan, S. (2009). Immunogenic Burkholderia pseudomallei outer membrane proteins as potential candidate vaccine targets. PLoS ONE 4:e6496. doi: 10.1371/journal.pone.0006496.
25. Harland, D. N., Dassa, E., Titbal, R. W., Brown, K. A., and Atkins, H. S. (2007). ATP-binding cassette systems in Burkholderia pseudomallei and Burkholderia mallei. BMC Genomics 8:83. doi: 10.1186/1471-2164-8-83.
26. Holden, M. T., Titbal, R. W., Peacock, S. J., Cerdeno-Tarraga, A. M., Atkins, T., Crossman, L. C., et al. (2004). Genomic plasticity of the causative agent of melioidosis, Burkholderia pseudomallei. Proc. Natl. Acad. Sci. U.S.A. 101, 14240-14245. doi: 10.1073/pnas.0403302101.
27. Jiao, Y., Wilkinson, J. IV, Di, X., Wang, W., Hatcher, H., Knock, N. D., et al. (2009). Curcumin, a cancer chemopreventive and chemotherapeutic agent, is a biologically active iron chelator. Blood 113, 462-469. doi: 10.1182/blood-2008-05-155952.
28. Jiao, Y., Wilkinson, J. IV, Pietsch, C. E., Buss, J. L., Wang, W., Planalp, R., et al. (2006). Iron chelation in the biological activity of curcumin. Free Radic. Biol. Med. 40, 1152-1160. doi: 10.1016/j.freeradbiomed.2005.11.003.
29. Koh, S. F., Tay, S. T., and Puthucheary, S. D. (2013). Colonial morphology and biofilm forming ability of Burkholderia pseudomallei. Trop. Biomed. 30, 428-433.
30. Kong, C., Tan, M. W., and Nathan, S. (2014b). Orthosiphon stamineus protects Caenorhabditis elegans against Staphylococcus aureus infection through immunomodulation. Biol. Open 3, 644-655. doi: 10.1186/1472-6882-14-4.
31. Kong, C., Yehye, W. A., Rahman, N. A., Tan, M. W., and Nathan, S. (2014a). Discovery of potential anti-infectives against Staphylococcus aureus using a Caenorhabditis elegans infection model. BMC Complement. Altern. Med. 14:4. doi: 10.1242/bio.20148334.
32. Kouker, G., and Jaeger, K. E. (1987). Specific and sensitive plate assay for bacterial lipases. Appl. Environ. Microbiol. 53, 211-213.
33. Krewulak, K. D., and Vogel, H. J. (2008). Structural biology of bacterial iron uptake. Biochim. Biophys. Acta 1778, 1781-1804. doi: 10.1016/j.bbamem.2007.07.026.
34. Kumarasamy, K. K., Toleman, M. A., Walsh, T. R., Bagaria, J., Butt, F., Balakrishnan, R., et al. (2010). Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological and epidemiological study. Lancet Infect. Dis. 10, 597-602. doi: 10.1016/S1473-3099(10)70143-2.
35. Lee, S. H., Chong, C. E., Lim, B. S., Chai, S. J., Sam, K. K., Mohamed, R., et al. (2007). Burkholderia pseudomallei animal and human isolates from Malaysia exhibit different phenotypic characteristics. Diagn. Microbiol. Dis. 58, 263-270. doi: 10.1016/j.diagmicrobio.2007.01.002.
36. Lee, S. H., Ooi, S. K., Mahadi, N. M., Tan, M. W., and Nathan, S. (2011). Complete killing of Caenorhabditis elegans by Burkholderia pseudomallei is dependent on prolonged direct association with the viable pathogen. PLoS ONE 6:16707. doi: 10.1371/journal.pone.0016707.
37. Lee, S. H., Wong, R. R., Chin, C. Y., Lim, T. Y., Eng, S. A., Kong, C., et al. (2013). Burkholderia pseudomallei suppresses Caenorhabditis elegans immunity by specific degradation of a GATA transcription factor. Proc. Natl. Acad. Sci. U.S.A. 110, 15067-15072. doi: 10.1073/pnas.1311725110.
38. Liao, V. H., Yu, C. W., Chu, Y. J., Li, W. H., Hsieh, Y. C., and Wang, T. T. (2011). Curcumin-mediated lifespan extension in Caenorhabditis elegans. Mech. Ageing Dev. 132, 480-487. doi: 10.1016/j.mad.2011.07.008.
39. Li, S., Yuan, W., Deng, G., Wang, P., and Aggarwal, B. B. (2011). Chemical composition and product quality control of turmeric (Curcuma longa L.). Pharm. Crops 2, 28-54. doi: 10.2174/2210290601102010028.
40. Limmathurosatkul, D., Wongratanacheewin, S., Teerawattanasook, N., Wongsuvan, G., Chaisuknant, S., Chetchotisakd, P., et al. (2010). Increasing incidence of human melioidosis in northeast Thailand. Am. J. Trop. Med. Hyg. 82, 1113-1117. doi: 10.4269/ajtmh.2010.10-0038.
41. Marathe, S. A., Ray, S., and Chakravortty, D. (2010). Curcumin increases the pathogenicity of Salmonella enterica serovar Typhimurium in murine model. PLoS ONE 5:e11511. doi: 10.1371/journal.pone.0011511.
42. Moghadamtousi, S. Z., Kadir, H. A., Hassandarvish, P., Tajik, H., Abubakar, S., and Zandi, K. (2014). A review on antibacterial, antiviral, and antifungal activity of curcumin. Biomed. Res. Int. 2014:186864. doi: 10.1155/2014/186864.
43. Moy, T. I., Ball, A. R., Anklesaria, Z., Casadei, G., Lewis, K., and Ausubel, F. M. (2006). Identification of novel antimicrobials using a live-animal model system. Proc. Natl. Acad. Sci. U.S.A. 103, 10414-10419. doi: 10.1073/pnas.0604055103.
44. Neelakantan, P., Subbarao, C., Sharma, S., Subbarao, C. V., Garcia-Godoy, F., and Gutman, J. L. (2013). Effectiveness of curcumin against Enterococcus faecalis biofilm. Acta. Odontol. Scand. 71, 1453-1457. doi: 10.3109/00016357.2013.769627.
45. Newman, D. J., and Cragg, G. M. (2012). Natural products as sources of new drugs over the 30 years from 1981 to 2010. J. Nat. Prod. 75, 311-335. doi: 10.1021/np200906s.
46. Nijnik, A. (2013). Immunomodulatory approaches for prevention and treatment of infectious diseases. Curr. Opin. Microbiol. 16, 590-595. doi: 10.1016/j.mib.2013.06.011.
47. Ooi, S. K., Lim, T. Y., Lee, S. H., and Nathan, S. (2012). Burkholderia pseudomallei kills Caenorhabditis elegans through virulence mechanism distinct from intestinal lumen colonization. Virulence 3, 485-496. doi: 10.4161/viru.21808.
48. O'Quinn, A. L., Wiegand, E. M., and Jeddeloh, J. A. (2001). Burkholderia pseudomallei kills the nematode Caenorhabditis elegans using an endotoxin-mediated paralysis. Cell Microbiol. 3, 381-393. doi: 10.1046/j.1462-5822.2001.00118.x.
49. Packiavathy, I. A., Priya, S., Pandian, S. K., and Ravi, A. V. (2014). Inhibition of biofilm development of uropathogens by curcumin-an anti-quorum sensing agent from Curcuma longa. Food Chem. 148, 453-460. doi: 10.1016/j.foodchem.2012.08.002.
50. Papa, R., Artini, M., Cellini, A., Tilotta, M., Galano, E., Pucci, P., et al. (2013). A new anti-infective strategy to reduce the spreading of antibiotic resistance by the action on adhesion-mediated virulence factors in Staphylococcus aureus. Microb. Pathog. 63, 44-53. doi: 10.1016/j.micpath.2013.05.003.
51. Patel, N., Conojero, L., De Reynal, M., Easton, A., Bancroft, G. J., and Titball, R. W. (2011). Development of vaccines against Burkholderia pseudomallei. Front. Microbiol. 2:198. doi: 10.3389/fmicb.2011.00198.
52. Puah, S. M., Puthucheary, S. D., Wang, J. T., Pan, Y. J., and Chua, K. H. (2014). Molecular characterization of putative virulence determinants in Burkholderia pseudomallei. ScientificWorldJournal 2014:590803. doi: 10.1155/2014/590803.
53. Puthucheary, S. D., and Sam, I. C. (2012). Why is the response rate slow in ceftazidime therapy for melioidosis? Expert Rev. Anti. Infect. Ther. 10, 5-7. doi: 10.1586/eri.11.158.
54. Rodrigues, F., Sarkar-Tyson, M., Harding, S. V., Sim, S. H., Chua, H. H., Lin, C. H., et al. (2006). Global map of growth-regulated gene expression in Burkholderia pseudomallei, the causative agent of melioidosis. J. Bacteriol. 188, 8178-8188. doi: 10.1128/JB.01006-06.
55. Rudrappa, T., and Bais, H. P. (2008). Curcumin, a known phenolic from Curcuma longa, attenuates the virulence of Pseudomonas aeruginosa PA01 in whole plant and animal pathogenicity models. J. Agric. Food Chem. 56, 1955-1962. doi: 10.1021/jf072591j.
56. Sarabhai, S., Sharma, P., and Capalash, N. (2013). Ellagic acid derivatives from Terminalia chebula Retz. downregulate the expression of quorum sensing genes to attenuate Pseudomonas aeruginosa PAO1 virulence. PLoS ONE 8:e53441. doi: 10.1371/journal.pone.0053441.
57. Schwyn, B., and Neilands, J. B. (1987). Universal chemical assay for the detection and determination of siderophores. Anal. Biochem. 160, 47-56. doi: 10.1016/0003-2697(87)90612-9.
58. Shapira, M., and Tan, M. W. (2008). Genetic analyis of Caenorhabditis elegans innate immunity. Methods Mol. Biol. 415, 429-442. doi: 10.1007/978-1-59745-570-1_25.
59. Sikora, E., Scapagini, G., and Barbagallo, M. (2010). Curcumin, inflammation, ageing and age-related diseases. Immun. Ageing 17:1. doi: 10.1186/1742-4933-7-1.
60. Silva, B. S., and Dow, S. W. (2013). Development of Burkholderia mallei and pseudomallei vaccines. Front. Cell Infect. Microbiol. 3:10. doi: 10.3389/fcimb.2013.00010.
61. Tabara, H., Hills, R. J., Mello, C. C., Priess, J. R., and Kohara, Y. (1999). pos-1 encodes a cytoplasmic zinc-finger protein essential for germline specification in Caenorhabditis elegans. Development 126, 1-11.
62. Tan, M. W., Mahajan-Miklos, S., and Ausubel, F. M. (1999). Killing of Caenorhabditis elegans by Pseudomonas aeruginosa used to model mammalian bacterial pathogenesis. Proc. Natl. Acad. Proc. Sci. U.S.A. 96, 715-720. doi: 10.1073/pnas.96.2.715.
63. Tuanyok, A., Kim, H. S., Nierman, W. C., Yu, Y., Dunbar, J., Moore, R. A., et al. (2005). Genome-wide expression of iron regulation in Burkholderia pseudomallei and Burkholderia mallei using DNA microarray. FEMS Microbiol. Lett. 252, 327-335. doi: 10.1016/j.femsle.2005.09.043.
64. Wiegand, I., Hilpert, K., and Hancock, R. E. W. (2008). Agar and broth dilution method to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat. Protoc. 3, 163-175. doi: 10.1038/nprot.2007.521.
65. Wiersinga, W. J., van der Poll, T., White, N. J., Day, N. P., and Peacock, S. J. (2006). Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei. Nat. Rev. Microbiol. 4, 272-282. doi: 10.1038/nrmicro1385.
66. Wuthiekanun, V., Amornchai, P., Saoprom, N., Chantratita, N., Chierakul, W., Koh, G. C. K. W., et al. (2011). Survey of antimicrobial resistance in clinical Burkholderia pseudomallei isolates over two decades in northeast Thailand. Antimicrob. Agents Chemother. 55, 5388-5391. doi: 10.1128/AAC.05517-11.
67. Yang, H., Kooi, C. D., and Sokol, P. A. (1993). Ability of Pseudomonas pseudomallei malleobactin to acquire transferrin-bound, lactoferrin-bound, and cell-derived iron. Infect. Immun. 61, 656-662.
68. Zilberberg, M. D., and Shorr, A. F. (2013). Prevalence of multidrug-resistant Pseudomonas aeruginosa and carbapenem-resistant Enterobacteriaceae among specimens from hospitalized patients with pneumonia and bloodstream infections in the United States from 2000 to 2009. J. Hosp. Med. 8, 559-563. doi: 10.1002/jhm.2080.